Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2131 AL 2145

Carbon Nanomaterial-Based Electrochemical Biosensors for Alzheimer's Disease Biomarkers: Progress, Challenges, and Future Perspectives

Şak B, Sousa HBA, Prior JAV.

Biosensors (Basel). 2025 Oct 9;15(10):684. doi: 10.3390/bios15100684.

The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases

Agnello L, Gambino CM, Ciaccio AM, Salemi G, Brighina F, Ragonese P, Piccoli T, Blandino V, Di Stefano V, Cacciabaudo F, Masucci A, Vassallo R, Scazzone C, Del Ben F, Ciaccio M.

Clin Chim Acta. 2025 May 15;572:120248. doi: 10.1016/j.cca.2025.120248. Epub 2025 Mar 18.

Clinical definition, biological characterization, and detection guidelines of subjective cognitive decline due to Alzheimer's disease and related dementia: A position paper from ISTAART SCD PIA

Moretti DV, Kuhn E, Dubbelmann MA, Sikkes SAM, Castilhos RM, Chapman S, Gifford KA, Butterbrod E, Nosheny RL; Subjective Cognitive Decline Professional Interest Area, Alzheimer's Association ISTAART.

Alzheimers Dement. 2025 Dec;21(12):e70847. doi: 10.1002/alz.70847.

Recent advances in nanomaterial-based biosensors for Alzheimer's disease diagnosis: a review

Liu Q, Xu X, Zheng T.

Chem Commun (Camb). 2025 Sep 4;61(72):13503-13522. doi: 10.1039/d5cc02469b.

The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease: Potential Biomarkers for Diagnosis

Abuduwaili Z, Fan Y, Tao W, Chen Y, Xu Y, Zhu X.

Curr Neuropharmacol. 2025;23(6):635-649. doi: 10.2174/011570159X337659241014140824.

Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia

Vollhardt A, Frölich L, Stockbauer AC, Danek A, Schmitz C, Wahl AS.

Neurobiol Dis. 2025 May;208:106845. doi: 10.1016/j.nbd.2025.106845. Epub 2025 Feb 24.

A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD

Erichsen JM, Register TC, Sutphen C, Ma D, Gaussoin SA, Rudolph M, Rundle M, Bateman JT, Lockhart SN, Sai KKS, Whitlow C, Craft S.

Alzheimers Dement. 2025 Oct;21(10):e70704. doi: 10.1002/alz.70704.

Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers

Shaabanpoor Haghighi A, Mayeli M, Ramezannezhad E, Pouroushaninia N, Barzegar Parizi R, Nourollahi-Foumeshi M, Idelkhani N, Dadjou Z, Saeedipour N, Safaee N, Partoandaz H, Shafie M, Sadeghi M, Falahati M; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2025 Nov;62(11):14156-14166. doi: 10.1007/s12035-025-05185-w. Epub 2025 Jul 16.

Boston University Alzheimer's Disease Research Center Clinical Core: Infrastructure to facilitate research on post-traumatic Alzheimer's disease and related dementias

Alosco ML, Morrison M, Au R, Steinberg EG, Mwicigi J, Ly M, Altaras C, Lenio S, Abdennadher M, O'Connor MK, Tripodis Y, Palmisano J, Dixon D, Martin B, Schneider G, Groh JR, Ellison A, Sheppard D, Farris CW, Nowinski C, Cantu RC, Turk KW, Farrer L, Jun G, Goldstein LE, Qiu WQ, Stein TD, Budson AE, McKee AC, Mez J.

Alzheimers Dement. 2025 Sep;21(9):e70654. doi: 10.1002/alz.70654.

Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential

García-de Soto J, Castro-Mosquera M, Pouso-Diz JM, Fernández-Cabrera A, Rodríguez-Arrizabalaga M, Debasa-Mouce M, Camino-Castiñeiras J, Minguillón Pereiro AM, Aramburu-Núñez M, Romaus-Sanjurjo D, Aldrey JM, Pego-Reigosa R, Pías-Peleteiro JM, Sobrino T, Ouro A.

Int J Mol Sci. 2025 Jul 23;26(15):7068. doi: 10.3390/ijms26157068.

Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

Serna MF, Mosquera M, García-Perdomo HA.

Neuromolecular Med. 2025 Jul 25;27(1):53. doi: 10.1007/s12017-025-08866-w.

Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers

Naiyeri A, Moqadami A, Khalaj-Kondori M.

Curr Gene Ther. 2025;25(5):646-662. doi: 10.2174/0115665232338503241227111640.

Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review

Kjaergaard D, Simonsen AH, Waldemar G, Nielsen TR.

J Alzheimers Dis. 2025 Jan;103(1):81-91. doi: 10.1177/13872877241299047. Epub 2025 Jan 15.

Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer's Disease

Wu F, Li W, Lu H, Li L.

Mol Cell Proteomics. 2025 Jul;24(7):101003. doi: 10.1016/j.mcpro.2025.101003. Epub 2025 May 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias